Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesSafety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension
The Journal of Headache and Pain, 11/25/09
Fontaine D et al. – During the randomized phase, no significant change in primary and secondary outcome measures was observed between active and sham stimulation. At the end of the open phase, 6/11 responded to the chronic stimulation (weekly frequency of attacks decrease >50%), including three pain–free patients. There were three serious adverse events, including subcutaneous infection, transient loss of consciousness and micturition syncopes. No significant change in hormonal functions or electrolytic balance was observed. Randomized phase findings of this study did not support the efficacy of DBS in refractory CCH, but open phase findings suggested long–term efficacy in more than 50% patients, confirming previous data, without high morbidity. Discrepancy between these findings justifies additional controlled studies.
Related Articles
Cluster Headache
Pain Practice, 11/03/09
Relevance Score: 82%
Stimulation-Induced Dyskinesia in the Early Stage after Subthalamic Deep Brain Stimulation
Stereotactic and Functional Neurosurgery, 11/25/09
Relevance Score: 80%
Deep brain stimulation as a new therapeutic approach in therapy-resistant mental disorders: ethical aspects of investigational treatment
European Archives of Psychiatry and Clinical Neuroscience, 11/10/09
Relevance Score: 80%
Deep Brain Stimulation Gives Hope For Very Severe Depression
ScienceDaily, 11/04/09
Relevance Score: 80%
CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine
Expert Review of Neurotherapeutics, 11/12/09
Relevance Score: 79%
Today in Headache...keeping you current
Receive free subspecialty "5-minute updates" via email
OnabotulinumtoxinA (botulinum toxin type-A) in the prevention of migraine
Expert Opinion on Biological Therapy, 02/09/10
User acceptance of an Internet training aid for migraine self-management
Journal of Telemedicine and Telecare, 02/09/10
Cerebral venous thrombosis initially presenting with left occipital hemorrhage and headache
Blood Coagulation & Fibrinolysis, 02/08/10
Today in Neurosurgery...keeping you current
Receive free subspecialty "5-minute updates" via email
Utility of a Three-Dimensional Endoscopic System in Skull Base Surgery
Skull Base, 02/09/10
Application of a flexible CO2 laser fiber for neurosurgery: laser-tissue interactions
Journal of Neurosurgery, 02/09/10
Endoscopic third ventriculostomy in the treatment of childhood hydrocephalus in Uganda: report of a scoring system that predicts success
Journal of Neurosurgery: Pediatrics, 02/09/10
Today in Pain Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
OnabotulinumtoxinA (botulinum toxin type-A) in the prevention of migraine
Expert Opinion on Biological Therapy, 02/09/10
Capsaicin jelly against migraine pain
International Journal of Clinical Practice, 02/09/10
Article Search
Sponsor
Sponsor